Page last updated: 2024-11-08

triiodothyronine and Granulocytic Leukemia, Chronic

triiodothyronine has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research Excerpts

ExcerptRelevanceReference
"To measure the levels of hormones in chronic myelogenous leukemia (CML) patients receiving imatinib mesylate (IM) and evaluate the effects of IM on endocrine system."1.39[Effects of imatinib mesylate on the levels of endocrine hormones]. ( Hou, Z; Liu, T; Zhu, HL, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hou, Z1
Zhu, HL1
Liu, T1
Földes, J1
Váradi, G1
Lakatos, P1
Bános, C1
Tarján, G1

Other Studies

2 other studies available for triiodothyronine and Granulocytic Leukemia, Chronic

ArticleYear
[Effects of imatinib mesylate on the levels of endocrine hormones].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia,

2013
Thyroid function in severe "nonthyroidal illness". Longitudinal studies in haematological patients.
    Acta medica Hungarica, 1989, Volume: 46, Issue:2-3

    Topics: Adult; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; L

1989